| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 4,081 | 1,722 |
| Provision for credit losses - loans | 1,790 | 2,000 |
| Recovery of credit losses - unfunded commitments | -99 | -44 |
| Depreciation and amortization (accretion) | -9,489 | -5,202 |
| Net change in net deferred loan origination costs | -32 | -27 |
| Loss on disposal of premises and equipment | -30 | -9 |
| Loss on sale of foreclosed assets | -18 | 0 |
| Foreclosed assets write-down | -1,163 | -635 |
| Loss on bank-owned life insurance | -1 | -1 |
| Gain on redemption of subordinated notes | 42 | 42 |
| Accrued interest receivable | -1,887 | -1,577 |
| Other assets | -359 | -560 |
| Accrued interest payable and other liabilities | -561 | 526 |
| Net cash (used in) from operating activities | -830 | 1,769 |
| Proceeds from maturities of interest-bearing time deposits in other financial institutions | 30,187 | 21,758 |
| Purchases of interest-bearing time deposits in other financial institutions | 7,875 | 7,875 |
| Proceeds from maturities | 633,400 | 362,900 |
| Proceeds from principal repayments | 348 | 255 |
| Purchases of securities | 798,843 | 432,762 |
| Net change in loans receivable | -124,709 | -88,386 |
| Bank-owned life insurance death benefit | -543 | -543 |
| Proceeds from sale of foreclosed assets | 1,353 | 1,203 |
| Proceeds from sale of premises and equipment | 0 | 0 |
| Purchase of premises and equipment, net | 751 | 509 |
| Net cash (used in) from investing activities | -16,929 | 33,899 |
| Deposits | 24,540 | -1,883 |
| Advance payments by borrowers for taxes and insurance | 5,334 | 1,578 |
| Repayments of federal home loan bank advances | 10,000 | 5,000 |
| Repurchase of subordinated notes | 464 | 464 |
| Repurchase and retirement of common stock | 0 | 0 |
| Cash dividends paid on common stock | 3,738 | 2,492 |
| Net cash from (used in) financing activities | 15,672 | -8,261 |
| Net change in cash and cash equivalents | -2,087 | 27,407 |
| Cash and cash equivalents at beginning of period | 84,829 | - |
| Cash and cash equivalents at end of period | 82,742 | - |
BankFinancial CORP (BFIN)
BankFinancial CORP (BFIN)